Parallel Advisors’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
SLG
PTC
Parallel Advisors's GDRX Position: Q3 2025 in Review
Parallel Advisors sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 13 shares — an estimated $65 sold.
Parallel Advisors first reported a position in GDRX in Q4 2020 and held it in 18 quarters. The position peaked at $758K in Q4 2020. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.
- Parallel Advisors reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
- Parallel Advisors sold 13 GoodRx Holdings shares in Q3 2025, an estimated $65.
- Parallel Advisors first reported a position in GoodRx Holdings in Q4 2020 and held it in 18 quarters.
- Parallel Advisors's GoodRx Holdings position peaked at $758K in Q4 2020.
- 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.
Based on Parallel Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.